Prescription patterns in patients with schizophrenia in Japan: First-quality indicator data from the survey of "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" project.
Neuropsychopharmacol Rep
; 40(3): 281-286, 2020 09.
Article
en En
| MEDLINE
| ID: mdl-32602667
ABSTRACT
BACKGROUND:
Guideline for Pharmacological Therapy for Schizophrenia was published by the Japanese Society of Neuropsychopharmacology in 2015. "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" project aimed to standardize medical practice using quality indicators (QIs) as indices to evaluate the quality of medical practice. In this study, we have reported the quality indicator values of prescription before the beginning of the guideline lectures in the EGUIDE project to ascertain the baseline status of treating patients with schizophrenia.METHODS:
A cross-sectional, retrospective case record survey was conducted, involving 1164 patients with schizophrenia at the time of discharge. We checked all types and dosage of psychotropic drugs.RESULTS:
Forty-three percent of patients had antipsychotic polypharmacy, and substantial concomitant medication was observed (antidepressants; 8%, mood stabilizers 37%, anxiolytics or hypnotics 68%).CONCLUSIONS:
In the results obtained in this study, we plant to report changes in the effectiveness of education in the EGUIDE project near the future.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Psiquiatría
/
Esquizofrenia
/
Pautas de la Práctica en Medicina
/
Guías de Práctica Clínica como Asunto
/
Indicadores de Calidad de la Atención de Salud
/
Prescripciones
Tipo de estudio:
Guideline
/
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
/
Qualitative_research
/
Risk_factors_studies
Límite:
Female
/
Humans
/
Male
País/Región como asunto:
Asia
Idioma:
En
Revista:
Neuropsychopharmacol Rep
Año:
2020
Tipo del documento:
Article
País de afiliación:
Japón